NCT04235634View on ClinicalTrials.gov

Intra-arterial Prostaglandin Therapy in Non-occlusive Mesenteric Ischemia

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

February 1, 2022

Conditions
Non-Occlusive Mesenteric Ischaemia (NOMI)
Interventions
DRUG

Prostavasin

Minimal invasive Cannulation of the Superior Mesenteric Artery (SMA) and subsequent intra-arterial application of prostaglandin E1 (Initial Bolus 20ug, followed by continuous Infusion of 60-80ug/24hr for 24-72hrs)

Trial Locations (1)

30625

Hannover Medical School, Hanover

All Listed Sponsors
lead

Hannover Medical School

OTHER

NCT04235634 - Intra-arterial Prostaglandin Therapy in Non-occlusive Mesenteric Ischemia | Biotech Hunter | Biotech Hunter